These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9327886)

  • 1. Ligand recognition by the vesicular monoamine transporters.
    Finn JP; Merickel A; Peter D; Edwards RH
    Adv Pharmacol; 1998; 42():232-6. PubMed ID: 9327886
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
    Merickel A; Rosandich P; Peter D; Edwards RH
    J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biochemical studies of rat vesicular monoamine transporter.
    Schuldiner S; Steiner-Mordoch S; Yelin R
    Adv Pharmacol; 1998; 42():223-7. PubMed ID: 9327884
    [No Abstract]   [Full Text] [Related]  

  • 4. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition.
    Merickel A; Kaback HR; Edwards RH
    J Biol Chem; 1997 Feb; 272(9):5403-8. PubMed ID: 9038139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP; Edwards RH
    J Biol Chem; 1998 Feb; 273(7):3943-7. PubMed ID: 9461580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
    Peter D; Vu T; Edwards RH
    J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional identification of vesicular monoamine and acetylcholine transporters.
    Varoqui H; Erickson JD
    Methods Enzymol; 1998; 296():84-99. PubMed ID: 9779442
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular pharmacology of the vesicular monoamine transporter.
    Henry JP; Sagné C; Botton D; Isambert MF; Gasnier B
    Adv Pharmacol; 1998; 42():236-9. PubMed ID: 9327887
    [No Abstract]   [Full Text] [Related]  

  • 9. A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines.
    Erickson JD
    Adv Pharmacol; 1998; 42():227-32. PubMed ID: 9327885
    [No Abstract]   [Full Text] [Related]  

  • 10. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters.
    Tan PK; Waites C; Liu Y; Krantz DE; Edwards RH
    J Biol Chem; 1998 Jul; 273(28):17351-60. PubMed ID: 9651318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
    Sagné C; Isambert MF; Vandekerckhove J; Henry JP; Gasnier B
    Biochemistry; 1997 Mar; 36(11):3345-52. PubMed ID: 9116013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of vesicular monoamine transporters: from classical techniques to histidine tags.
    Yelin R; Schuldiner S
    Methods Enzymol; 1998; 296():64-72. PubMed ID: 9779440
    [No Abstract]   [Full Text] [Related]  

  • 13. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles.
    Krantz DE; Waites C; Oorschot V; Liu Y; Wilson RI; Tan PK; Klumperman J; Edwards RH
    J Cell Biol; 2000 Apr; 149(2):379-96. PubMed ID: 10769030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.
    Waites CL; Mehta A; Tan PK; Thomas G; Edwards RH; Krantz DE
    J Cell Biol; 2001 Mar; 152(6):1159-68. PubMed ID: 11257117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane monoamine transporters: structure, regulation and function.
    Torres GE; Gainetdinov RR; Caron MG
    Nat Rev Neurosci; 2003 Jan; 4(1):13-25. PubMed ID: 12511858
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholamine metabolism: an update on key biosynthetic enzymes and vesicular monoamine transporters.
    Flatmark T; Almas B; Ziegler MG
    Ann N Y Acad Sci; 2002 Oct; 971():69-75. PubMed ID: 12438092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter.
    Sagné C; Isambert MF; Henry JP; Gasnier B
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):825-31. PubMed ID: 8670158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M; Weizman A; Rehavi M
    Life Sci; 2001 Sep; 69(19):2311-7. PubMed ID: 11669473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond.
    Thiriot DS; Sievert MK; Ruoho AE
    Biochemistry; 2002 May; 41(20):6346-53. PubMed ID: 12009896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.